Immunotherapy in Cancer: Incremental Gain or a Quantum Leap? - Wikidata - wikimedia - TriplyDB

Immunotherapy in Cancer: Incremental Gain or a Quantum Leap?

Immunotherapy in Cancer: Incremental Gain or a Quantum Leap?

http://www.wikidata.org/entity/Q42341631

about

Immunotherapy in Cancer: Incremental Gain or a Quantum Leap?

http://www.wikidata.org/entity/Q42341631

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Immunotherapy in Cancer: Incremental Gain or a Quantum Leap?

@en

Immunotherapy in Cancer: Incremental Gain or a Quantum Leap?

@nl

type

label

Immunotherapy in Cancer: Incremental Gain or a Quantum Leap?

@en

Immunotherapy in Cancer: Incremental Gain or a Quantum Leap?

@nl

prefLabel

Immunotherapy in Cancer: Incremental Gain or a Quantum Leap?

@en

Immunotherapy in Cancer: Incremental Gain or a Quantum Leap?

@nl

P1433

Q42341631-54BF8484-13EE-45B8-9708-E93B1DE7F8CE

P1476

Q42341631-E8DDEF9C-5697-43A9-9FD6-B18B31FF69CD

P2093

Q42341631-D81D0F18-A0AB-43F9-99C7-D7864B0D916E

P2860

Q42341631-511333CC-4E87-4DBB-85C1-D5AD74709E28

Q42341631-5F695174-72BD-4B41-B1D3-EB5EC08C0997

Q42341631-63A29764-D8B8-425A-93A0-0741039D0C02

Q42341631-7DDDB0FD-7401-4D81-8FA2-EDC68B5CE0D6

Q42341631-8524D7BD-A36F-44FB-A7E3-25DD58E2E57E

Q42341631-8B8A224C-2EF6-4E3F-8270-089A918D4E6F

Q42341631-A3932D12-9AAB-4B48-BB85-DDC4E6E3872D

Q42341631-B24C45FC-382D-420E-8124-942150BD052C

Q42341631-B36DDAC3-3D3E-4696-AE13-3A35149FA6B1

Q42341631-BB7C1F1D-102A-48D9-B638-C875EFB9F994

P304

Q42341631-E2A7149B-D6C3-4FFA-BF44-7129C6C43BA4

P31

Q42341631-4b9916c8-c6b0-4fa0-900b-2d7fd1835986

Q42341631-571AD8E0-1E3F-45B0-9063-C341EBF8B9EC

P356

Q42341631-CD8C36C3-783F-47FC-A3A9-B2D4C984B573

P433

Q42341631-69226D32-DA6B-4AEA-ACBD-705DD3BB1DCA

P478

Q42341631-0ED8E942-640E-4B45-863E-EF42B4F4A51E

P577

Q42341631-CAA240D0-289B-4A8A-9A38-88CD894E92C3

P698

Q42341631-C82E85E5-4861-4611-961B-80FBFB7B47A8

P921

Q42341631-2A2D19A5-A9D4-4BA0-8FB1-919187C39706

P932

Q42341631-23ACF787-01B5-4301-8B7C-6A027A1F8096

P356

P1433

Oman Medical Journal

P1476

Immunotherapy in Cancer: Incremental Gain or a Quantum Leap?

@en

P2093

Ikram A Burney

http://www.w3.org/2001/XMLSchema#string

P2860

Advances in immunotherapy for treatment of lung cancer

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Systemic therapy of metastatic melanoma: on the road to cure.

Therapeutic strategies for chronic myeloid leukemia in the chronic (stable) phase.

Biomarkers associated with checkpoint inhibitors.

Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.

Immune checkpoint inhibitors for cancer treatment.

Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.

P304

1-2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5001/OMJ.2017.01

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28042395

http://www.w3.org/2001/XMLSchema#string

P921

P932

5187407

http://www.w3.org/2001/XMLSchema#string